Neighbourly Pharmacy, which went public this year, has launched a secondary and treasury bought deal offering that will generate about C$130 million in proceeds.
To read this article, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
New to PE Hub?
Register now to read this article and more for free.
